Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arch. endocrinol. metab. (Online) ; 65(2): 185-197, Mar.-Apr. 2021. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1248805

RESUMO

ABSTRACT Objective: The main aim of the study was to evaluate the patients' glycemic control and adherence to self-care tasks. Materials and methods: Patients with type 1 diabetes mellitus (T1DM) or latent autoimmune diabetes of the adult (LADA) using a multiple daily injection (MDI) regimen with carbohydrate counting (n = 25, Subgroup B) or fixed insulin dose (n = 25, Subgroup C) were allocated to use the application (app) for 12 weeks. Both subgroups were compared with each other and against a control group (n = 25, Group A) comprising patients with T1DM or LADA treated with continuous subcutaneous insulin infusion (CSII) in a parallel-group, open-label, clinical treatment trial. All patients had glycated hemoglobin (A1C) levels measured and were asked to fill out the Diabetes Self-Management Profile (DSMP) questionnaire at study start and end. The patients were instructed to measure capillary glucose six times daily in study weeks 4, 8, and 12. Results: Mean A1C levels decreased 0.725% in Subgroup C in intragroup analysis (p = 0.0063), and had a mean variation of 0.834% compared with Group A (p = 0.003). Mean DSMP scores increased 5.77 points in Subgroup B in intragroup analysis (p = 0.0004) and increased by a mean of 6.815 points in relation to Group A (p = 0.002). Conclusion: OneTouch Reveal improved both A1C levels and DSMP scores in patients with T1DM or LADA compared with standard treatment (CSII).


Assuntos
Humanos , Adulto , Diabetes Mellitus Tipo 1/tratamento farmacológico , Aplicativos Móveis , Autocuidado , Glicemia/análise , Hemoglobinas Glicadas/análise , Sistemas de Infusão de Insulina , Controle Glicêmico , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico
2.
Arch. endocrinol. metab. (Online) ; 59(5): 455-459, Oct. 2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-764121

RESUMO

Brown tumors are rare skeletal manifestations that occur in less than 2% of primary hyperparathyroidism (PHPT) cases. Even rarer is the occurrence of brown tumor of the orbit, and few cases have been reported around the world. The rare instance of this benign tumor has prompted us to report the case and treatment of an orbital brown tumor in a patient with PHPT caused by parathyroid adenoma. We present the case of a patient undergoing follow-up at a referral center. The 60-year-old female patient, presented herself with progressive swelling in the nasal region, epistaxis and proptosis, she had noticed seven months prior to our examination. Multiple imaging and laboratory findings revealed parathyroid hormone (PTH)-dependent hypercalcemia (total calcium = 14.3 mg/dL and PTH = 1,573 pg/mL), a nodular lesion in the upper pole of the left thyroid lobe and increased uptake in left upper cervical region. The patient underwent left superior parathyroidectomy in September 2011, which led to the normalization of hypercalcemia and regression of the orbital tumor, as seen on control CT scan. This case highlights the spontaneous regression of the brown tumor after surgical management of the parathyroid adenoma.


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Adenoma/cirurgia , Hiperparatireoidismo Primário/diagnóstico , Doenças Orbitárias/patologia , Neoplasias das Paratireoides/cirurgia , Adenoma , Densidade Óssea , Cálcio/sangue , Doenças Orbitárias , Paratireoidectomia , Neoplasias das Paratireoides , Remissão Espontânea , Tomografia Computadorizada por Raios X
3.
Arch Endocrinol Metab ; 59(5): 455-9, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26331231

RESUMO

Brown tumors are rare skeletal manifestations that occur in less than 2% of primary hyperparathyroidism (PHPT) cases. Even rarer is the occurrence of brown tumor of the orbit, and few cases have been reported around the world. The rare instance of this benign tumor has prompted us to report the case and treatment of an orbital brown tumor in a patient with PHPT caused by parathyroid adenoma. We present the case of a patient undergoing follow-up at a referral center. The 60-year-old female patient, presented herself with progressive swelling in the nasal region, epistaxis and proptosis, she had noticed seven months prior to our examination. Multiple imaging and laboratory findings revealed parathyroid hormone (PTH)-dependent hypercalcemia (total calcium = 14.3 mg/dL and PTH = 1,573 pg/mL), a nodular lesion in the upper pole of the left thyroid lobe and increased uptake in left upper cervical region. The patient underwent left superior parathyroidectomy in September 2011, which led to the normalization of hypercalcemia and regression of the orbital tumor, as seen on control CT scan. This case highlights the spontaneous regression of the brown tumor after surgical management of the parathyroid adenoma.


Assuntos
Adenoma/cirurgia , Hiperparatireoidismo Primário/diagnóstico , Doenças Orbitárias/patologia , Neoplasias das Paratireoides/cirurgia , Adenoma/diagnóstico por imagem , Densidade Óssea , Cálcio/sangue , Feminino , Humanos , Pessoa de Meia-Idade , Doenças Orbitárias/diagnóstico por imagem , Neoplasias das Paratireoides/diagnóstico por imagem , Paratireoidectomia , Cintilografia , Remissão Espontânea , Tomografia Computadorizada por Raios X
4.
Arq. bras. cardiol ; 102(5,supl.1): 1-41, 05/2014. tab
Artigo em Inglês | LILACS | ID: lil-709328
5.
Arq Bras Cardiol ; 102(5 Suppl 1): 1-41, 2014 05.
Artigo em Português | MEDLINE | ID: mdl-27223869
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...